Barclays
FLXN

Barclays’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Barclays’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,300
Closed -$37K – 7470
2018
Q4 		$37K Buy
+3,300
New +$51.7K ﹤0.01% 5633

Barclays's FLXN Position: Q4 2021 in Review

Barclays sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 100,547 shares — an estimated $614K sold.

Barclays first reported a position in FLXN in Q1 2014 and held it in 31 quarters. The position peaked at $3.64M in Q4 2019. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

  • Barclays reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 100,547 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $614K.
  • Barclays first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 31 quarters.
  • Barclays's Flexion Therapeutics, Inc. position peaked at $3.64M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.